This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jul 25;122(4):470-1.

doi: 10.1182/blood-2013-06-506097.

TWIST it but don't spin it

Jane F Apperley¹

Affiliations

PMID: 23886774
DOI: 10.1182/blood-2013-06-506097

Free article

Comment

TWIST it but don't spin it

Jane F Apperley. Blood. 2013.

Free article

. 2013 Jul 25;122(4):470-1.

doi: 10.1182/blood-2013-06-506097.

Author

Jane F Apperley¹

Affiliation

¹ Imperial College London, UK.

PMID: 23886774
DOI: 10.1182/blood-2013-06-506097

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study.
Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Yeung DT, Dang P, Goyne JM, Slader C, Filshie RJ, Mills AK, Melo JV, White DL, Grigg AP, Hughes TP. Ross DM, et al. Blood. 2013 Jul 25;122(4):515-22. doi: 10.1182/blood-2013-02-483750. Epub 2013 May 23. Blood. 2013. PMID: 23704092 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information